3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling
- Written by PR Newswire
REYKJAVIK, Iceland and BERLIN, Aug. 18, 2023 /PRNewswire/ -- Reykjavik-based drug discovery company, 3Z, and Germany/US-based causal AI firm, biotx.ai, have joined forces in a strategic partnership aimed at revolutionizing ADHD drug development. By leveraging advanced AI modelling techniques, the collaboration seeks to bridge the gap between...
Read more: 3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling